OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00079557

Innuovo Technology Co Ltd

Commodity ChemicalsVerified

Innuovo Technology maintains a relatively strong liquidity position with a current ratio of 2.12, indicating the company can cover its short-term obligations with its current assets. However, the company's free cash flow is negative at -127.2 million CNY, and capital expenditures are significant at -215.3 million CNY, suggesting ongoing investment in operations. The company's debt-to-equity ratio is 0.1, reflecting a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 9.43% and a return on assets (ROA) of 5.87%, both of which are in line with the industry's preferred metrics for commodity chemical producers. The company's net income of 249.96 million CNY and operating income of 282.68 million CNY indicate stable earnings performance. Gross profit of 687.36 million CNY suggests moderate pricing power in a competitive industry. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's revenue is entirely derived from its core chemical production activities, with no material contributions from other business lines. Looking ahead, the company is expected to maintain its current revenue level, with no significant growth or contraction projected in the next fiscal year. The company's capital expenditures are expected to remain high, driven by ongoing investments in production capacity and operational efficiency. The company's free cash flow is expected to remain negative in the near term, as capital expenditures outpace operating cash flow. The company faces moderate liquidity risk due to its negative net cash position after subtracting total debt. While the company's debt-to-equity ratio is low, the negative free cash flow and high capital expenditures could strain liquidity if revenue growth does not materialize. The company's dilution risk is currently low, with no near-term pressure from share issuance or convertible debt. However, the company's capital structure could shift if it requires additional financing to fund its expansion plans. Recent filings and transcripts indicate that the company is focused on expanding its production capacity and improving operational efficiency. The company has not disclosed any material legal or regulatory issues, and its risk assessment remains stable. The company's management has emphasized the importance of maintaining a strong balance sheet and managing working capital effectively.

30-day price · 000795+0.14 (+1.6%)
Low$8.57High$9.93Close$8.89As of22 May, 00:00 UTC
Profile
CompanyInnuovo Technology Co Ltd
Ticker000795.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Innuovo Technology Co Ltd is a Chinese chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products.

Classification. Innuovo Technology is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Innuovo Technology maintains a relatively strong liquidity position with a current ratio of 2.12, indicating the company can cover its short-term obligations with its current assets. However, the company's free cash flow is negative at -127.2 million CNY, and capital expenditures are significant at -215.3 million CNY, suggesting ongoing investment in operations. The company's debt-to-equity ratio is 0.1, reflecting a conservative capital structure with limited leverage. Profitability metrics show a return on equity (ROE) of 9.43% and a return on assets (ROA) of 5.87%, both of which are in line with the industry's preferred metrics for commodity chemical producers. The company's net income of 249.96 million CNY and operating income of 282.68 million CNY indicate stable earnings performance. Gross profit of 687.36 million CNY suggests moderate pricing power in a competitive industry. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's revenue is entirely derived from its core chemical production activities, with no material contributions from other business lines. Looking ahead, the company is expected to maintain its current revenue level, with no significant growth or contraction projected in the next fiscal year. The company's capital expenditures are expected to remain high, driven by ongoing investments in production capacity and operational efficiency. The company's free cash flow is expected to remain negative in the near term, as capital expenditures outpace operating cash flow. The company faces moderate liquidity risk due to its negative net cash position after subtracting total debt. While the company's debt-to-equity ratio is low, the negative free cash flow and high capital expenditures could strain liquidity if revenue growth does not materialize. The company's dilution risk is currently low, with no near-term pressure from share issuance or convertible debt. However, the company's capital structure could shift if it requires additional financing to fund its expansion plans. Recent filings and transcripts indicate that the company is focused on expanding its production capacity and improving operational efficiency. The company has not disclosed any material legal or regulatory issues, and its risk assessment remains stable. The company's management has emphasized the importance of maintaining a strong balance sheet and managing working capital effectively.
Key takeaways
  • Innuovo Technology maintains a conservative capital structure with a low debt-to-equity ratio of 0.1.
  • The company's free cash flow is negative, driven by high capital expenditures of -215.3 million CNY.
  • Profitability metrics, including ROE of 9.43% and ROA of 5.87%, are in line with industry norms.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional and industry-specific risks.
  • Liquidity risk is moderate due to a negative net cash position after subtracting total debt.
  • The company's dilution risk is currently low, with no near-term pressure from share issuance.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.88B
Gross profit$687.4M
Operating income$282.7M
Net income$250.0M
R&D
SG&A
D&A
SBC
Operating cash flow$342.2M
CapEx-$215.3M
Free cash flow-$127.2M
Total assets$4.26B
Total liabilities$1.61B
Total equity$2.65B
Cash & equivalents
Long-term debt$274.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.88B$282.7M$250.0M-$127.2M
FY-1$4.01B$269.9M$247.6M$123.4M
FY-2$4.04B$108.9M$89.6M-$8.2M
FY-3$4.73B$268.7M$258.5M$173.6M
FY-4$3.76B$129.9M$135.4M$60.3M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$4.26B$2.65B
FY-1$4.13B$2.69B
FY-2$4.52B$2.70B
FY-3$4.95B$2.70B
FY-4$4.48B$2.48B
PeriodOCFCapExFCFSBC
FY0$342.2M-$215.3M-$127.2M
FY-1$585.0M-$194.7M$123.4M
FY-2$385.2M-$91.8M-$8.2M
FY-3$64.8M-$137.8M$173.6M
FY-4-$129.7M-$146.5M$60.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$981.4M$75.8M$69.3M
FQ-1$1.16B$53.4M$49.2M
FQ-2$993.2M$64.8M$56.8M
FQ-3$894.0M$85.8M$75.1M
FQ-4$839.7M$79.1M$68.8M
FQ-5$1.14B$26.9M$41.2M
FQ-6$992.5M$75.0M$64.1M
FQ-7$1.14B$97.5M$77.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$4.45B$2.72B$647.6M
FQ-1$4.26B$2.65B
FQ-2$4.12B$2.60B$555.1M
FQ-3$4.00B$2.69B
FQ-4$3.93B$2.75B$732.7M
FQ-5$4.13B$2.69B
FQ-6$3.90B$2.69B$813.7M
FQ-7$3.99B$2.65B
PeriodOCFCapExFCFSBC
FQ0-$230.8M-$57.8M
FQ-1$342.2M-$215.3M
FQ-2$202.9M-$139.4M
FQ-3$60.5M-$83.8M
FQ-4$103.4M-$36.2M
FQ-5$585.0M-$194.7M
FQ-6$443.9M-$101.2M
FQ-7$234.1M-$69.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.65B
Net cash-$274.5M
Current ratio2.1
Debt/Equity0.1
ROA5.9%
ROE9.4%
Cash conversion1.4%
CapEx/Revenue-5.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000795Activity
Op margin7.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.4%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin17.7%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity10.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual revenue3,884,305,510 CNY
Mean EBIT estimate377,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:33 UTCJob: 9ccb7d0a